by According to Precedence Research, during the forecast period of 2022 to 2030, the global probiotic ingredients market is estimated to develop at a compound annual growth rate (CAGR) of 12.42%. The global probiotic ingredients market was valued at USD 4,973.5 million in 2021, and it is predicted to exceed USD 14,269 million by 2030. The study investigates several elements and their consequences on the growth of the probiotic ingredients market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1826
This report focuses on probiotic ingredients market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall probiotic ingredients market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
Report Scope of the Probiotic Ingredients Market
| Report Coverage | Details |
| Market Size by 2030 | USD 14,269 Million |
| Growth Rate from 2022 to 2030 | CAGR of 12.42% |
| Europe Market Share in 2021 | 38% |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | ProbioFerm, Glac Biotech, DSM, Vitakem Nutraceutical, Inc., Bio Gaia, Probium, Kerry Group |
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of probiotic ingredients, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of probiotic ingredients has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the probiotic ingredients market.
Some of the prominent players in the probiotic ingredients market include:
- ProbioFerm
- Glac Biotech
- DSM
- Vitakem Nutraceutical, Inc.
- Bio Gaia
- Probium
- Kerry Group
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1826
Segments Covered in the Report
By Type
- Bifidobacterium animalis
- Bifidobacterium breve
- Bifidobacterium longum
- Lactobacillus Reuteri
By Application
- Food and Beverages
- Dairy Products
- Yogurt
- Cheese
- Other
- Non-dairy Products
- Vegetable-based probiotic products
- Fruit-based probiotic products
- Meat-based probiotic products
- Dairy Products
- Dietary Supplements
- Tablets
- Probiotic Drinks
- Powders
- Capsules
- Powder
- Granule
- Animal Feed
By Components
- Bacterica
- Yeast
By Form
- Dry Form
- Liquid Form
By End User
- Human Probiotic
- Animal Probiotic
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Probiotic Ingredients Market
5.1. COVID-19 Landscape: Probiotic Ingredients Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Probiotic Ingredients Market, By Type
8.1. Probiotic Ingredients Market, by Type, 2022-2030
8.1.1. Bifidobacterium animalis
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Bifidobacterium breve
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Bifidobacterium longum
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Lactobacillus Reuteri
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Probiotic Ingredients Market, By Application
9.1. Probiotic Ingredients Market, by Application, 2022-2030
9.1.1. Food and Beverages
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Dietary Supplements
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Animal Feed
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Probiotic Ingredients Market, By Components
10.1. Probiotic Ingredients Market, by Components, 2022-2030
10.1.1. Bacterica
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Yeast
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Probiotic Ingredients Market, By Form
11.1. Probiotic Ingredients Market, by Form, 2022-2030
11.1.1. Dry Form
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Liquid Form
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Probiotic Ingredients Market, By End User
12.1. Probiotic Ingredients Market, by End User, 2022-2030
12.1.1. Human Probiotic
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Animal Probiotic
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Probiotic Ingredients Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.3. Market Revenue and Forecast, by Components (2017-2030)
13.1.4. Market Revenue and Forecast, by Form (2017-2030)
13.1.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Components (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Form (2017-2030)
13.1.7. Market Revenue and Forecast, by End User (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Components (2017-2030)
13.1.8.4. Market Revenue and Forecast, by Form (2017-2030)
13.1.8.5. Market Revenue and Forecast, by End User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.3. Market Revenue and Forecast, by Components (2017-2030)
13.2.4. Market Revenue and Forecast, by Form (2017-2030)
13.2.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Components (2017-2030)
13.2.7. Market Revenue and Forecast, by Form (2017-2030)
13.2.8. Market Revenue and Forecast, by End User (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Components (2017-2030)
13.2.10. Market Revenue and Forecast, by Form (2017-2030)
13.2.11. Market Revenue and Forecast, by End User (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Components (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Form (2017-2030)
13.2.13. Market Revenue and Forecast, by End User (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Components (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Form (2017-2030)
13.2.15. Market Revenue and Forecast, by End User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.3. Market Revenue and Forecast, by Components (2017-2030)
13.3.4. Market Revenue and Forecast, by Form (2017-2030)
13.3.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Components (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Form (2017-2030)
13.3.7. Market Revenue and Forecast, by End User (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Components (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Form (2017-2030)
13.3.9. Market Revenue and Forecast, by End User (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Components (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Form (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Components (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Form (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.3. Market Revenue and Forecast, by Components (2017-2030)
13.4.4. Market Revenue and Forecast, by Form (2017-2030)
13.4.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Components (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Form (2017-2030)
13.4.7. Market Revenue and Forecast, by End User (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Components (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Form (2017-2030)
13.4.9. Market Revenue and Forecast, by End User (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Components (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Form (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Components (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Form (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.3. Market Revenue and Forecast, by Components (2017-2030)
13.5.4. Market Revenue and Forecast, by Form (2017-2030)
13.5.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Components (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Form (2017-2030)
13.5.7. Market Revenue and Forecast, by End User (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Components (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Form (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)
Chapter 14. Company Profiles
14.1. ProbioFerm
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Glac Biotech
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. DSM
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Vitakem Nutraceutical, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bio Gaia
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Probium
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Kerry Group
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1826
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
